202 COUSTEAU PLACE, DAVIS, X1
Consolidated Balance Sheets (Unaudited)
Deloitte Dismissed as Independent Auditor for Arcadia Biosciences
Financial Results, Press Release
Director Resignations - Albert Bolles and Deborah Carosella Step Down
Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds
Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources
Shareholder votes
Annual Report to Security Holders
Q1
Amended Annual Report
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
RW
Prospectus Filed Pursuant to Rule 425
S-4/A
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Registration of Securities under Section 12(g)